Fertility-Sparing Gynae Oncology
On this page
Direct answer
Fertility preservation in gynaecological cancer is governed less by the tumour type than by its stage, and four settings account for almost every legitimate indication. Early cervical cancer: stage IA1 without lymphovascular space invasion is cured by conisation alone; IA1 with LVSI or IA2 may be managed by conisation or simple trachelectomy with pelvic lymphadenectomy; select IB1 tumours up to about 2 cm qualify for radical trachelectomy, with recent trial support for conisation with nodal assessment in low-risk lesions. Endometrial cancer: atypical hyperplasia and grade 1 endometrioid carcinoma with no more than superficial myometrial invasion, confirmed on MRI and hysteroscopy, can be treated with progestins under strict surveillance. Ovarian cancer: malignant germ cell tumours are the poster child — unilateral adnexectomy with staging and platinum-based chemotherapy preserves the uterus and other ovary at any age; early epithelial cancers (stage IA grade 1-2) and borderline tumours also qualify. Each pathway pairs the operation with an honest recurrence conversation and a delivery plan heavy on caesarean sections.
What you must remember
- Cervical ladder: IA1 without LVSI — cone with clear margins (fertility fully preserved); IA1 with LVSI and IA2 — conisation or simple trachelectomy plus pelvic lymphadenectomy; IB1 up to 2 cm — radical trachelectomy with lymphadenectomy; tumours over 2 cm or high-risk histology fall out of the bracket.
- Sentinel node era: sentinel lymph node biopsy is increasingly replacing full lymphadenectomy in early cervical and endometrial fertility protocols — the contemporary nodal answer.
- Endometrial protocol: hysteroscopy with directed biopsy and MRI to exclude deep invasion; levonorgestrel intrauterine system or high-dose progestin for six months, repeat sampling six-monthly until two consecutive negatives, weight loss as therapy; hysterectomy after childbearing.
- Germ cell tumour rules: unilateral salpingo-oophorectomy with staging; BEP chemotherapy (bleomycin, etoposide, cisplatin) beyond the earliest stages; fertility outcomes are good, with most survivors menstruating.
- Epithelial ovarian criteria: stage IA, grade 1-2, one ovary, capsule intact — unilateral salpingo-oophorectomy with full staging; anything beyond stage IA forfeits the option outside trials.
- Sex-cord stromal: granulosa and Sertoli-Leydig tumours — unilateral surgery acceptable for stage I; granulosa tumours recur late, so surveillance continues a decade.
- Obstetric price tag: post-trachelectomy pregnancies carry preterm birth, mid-trimester loss and cervical incompetence; cerclage planning and high-risk antenatal care are part of consent.
- Indian context: the cervical cancer cohort skews younger than in high-income countries, making these pathways disproportionately relevant; HPV vaccination of the survivor prevents new disease.
A worked example across two cancers
A 27-year-old, nulligravida, has a 1.8 cm squamous carcinoma of the cervix, FIGO IB1, with clear MRI and negative nodes. Her pathway: laparoscopic pelvic sentinel node biopsy or lymphadenectomy — if negative, a radical trachelectomy removes the cervix, upper vagina and parametria while the uterine body and its vessels are preserved, and a cerclage is placed at the isthmus. She is counselled that conception may need assistance, that miscarriage and preterm birth rates are elevated, and that every future delivery is a caesarean. Contrast a 22-year-old with a 14 cm solid ovarian mass: her raised LDH points the germ cell panel (LDH, AFP, beta-hCG, inhibin) toward a germ cell tumour, and frozen section confirms dysgerminoma. Her surgery is unilateral adnexectomy with staging — the uterus and other ovary stay — followed by BEP chemotherapy, after which she is counselled about regular cycles and future pregnancy. Both women keep fertility not through leniency but because stage and histology earned it on trial evidence.
Where students slip
The classic error is treating "fertility-sparing" as a single operation rather than a stage-matched menu — offering trachelectomy for a 4 cm tumour or progestins for a grade 3 endometrial cancer. The second is forgetting the lymph nodes: fertility-sparing cervical surgery always pairs with nodal assessment, because the uterine body is preserved only if the nodes are negative. The third is surveillance laxity — endometrial progestin protocols fail or relapse silently, and the exam expects six-monthly histology until two consecutive negatives. A subtle one: germ cell tumours need markers for follow-up (AFP for yolk sac, beta-hCG for choriocarcinoma, LDH for dysgerminoma, inhibin for granulosa), and candidates who cannot pair marker to tumour lose easy marks.
Frequently asked questions
Which cervical cancer stage is treated by conisation alone?
Stage IA1 squamous carcinoma without lymphovascular space invasion, provided cone margins are clear — cure rates match hysterectomy.
What is a radical trachelectomy and who qualifies?
Removal of the cervix, upper vagina and parametria with pelvic lymphadenectomy while preserving the uterine body, offered for early cervical cancers up to about 2 cm in women desiring fertility.
Which endometrial cancers are eligible for progestin therapy?
Atypical hyperplasia and grade 1 endometrioid carcinoma without deep myometrial invasion, confirmed on MRI and hysteroscopy, in counselled fertility-seekers.
Why are germ cell tumours uniquely amenable to fertility-sparing surgery?
They are unilateral, chemo-sensitive and occur in the young, so unilateral adnexectomy with BEP chemotherapy cures most while preserving the uterus and contralateral ovary.
What are the obstetric consequences of trachelectomy?
Cervical incompetence with mid-trimester loss, high preterm birth rates, and obligatory caesarean delivery in subsequent pregnancies.